Aquatic Capital Management’s Alpine Immune Sciences Inc ALPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-1,200
Closed -$47.6K 1678
2024
Q1
$47.6K Sell
1,200
-200
-14% -$5.9K ﹤0.01% 1034
2023
Q4
$27K Buy
1,400
+1,200
+600% +$16.7K ﹤0.01% 1196
2023
Q3
$2K Buy
+200
New +$2.46K ﹤0.01% 1195

Aquatic Capital Management's ALPN Position: Q2 2024 in Review

Aquatic Capital Management sold out of Alpine Immune Sciences Inc (ALPN) in Q2 2024, closing a stake of 1,200 shares — an estimated $47.6K sold.

Aquatic Capital Management first reported a position in ALPN in Q3 2023 and held it in 3 quarters. The position peaked at $47.6K in Q1 2024. 0 funds tracked by Wall St. Rank hold ALPN as of Q2 2024.

  • Aquatic Capital Management reported no remaining Alpine Immune Sciences Inc position as of Q2 2024 after selling out during the quarter.
  • Aquatic Capital Management sold 1,200 Alpine Immune Sciences Inc shares in Q2 2024, an estimated $47.6K.
  • Aquatic Capital Management first reported a position in Alpine Immune Sciences Inc in Q3 2023 and held it in 3 quarters.
  • Aquatic Capital Management's Alpine Immune Sciences Inc position peaked at $47.6K in Q1 2024.
  • 0 funds tracked by Wall St. Rank held Alpine Immune Sciences Inc as of Q2 2024.

Based on Aquatic Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.